We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Buy MNMD near 5.51 target 7.67 stop loss @ 5.49 Details The technical summary data tells us to buy MNMD near 5.51 with an upside target of 7.67. This data also tells us to set a stop loss @ 5.49 to ...

(NASDAQ:MNMD – Free Report) by 9.9% in the third quarter, according to its most recent 13F filing with the Securities and ...

NEW YORK, December 19, 2024--Mind Medicine (MindMed) Inc. (Nasdaq: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain ...

The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $27.71. MNMD has been the subject of a number of research analyst reports.

Fintel reports that on December 20, 2024, Chardan Capital initiated coverage of Mind Medicine (NasdaqGS:MNMD) with a Buy ...

As of 2:03:17 PM EST. Market Open.

Oppenheimer analyst Francois Brisebois maintained a Buy rating on Mind Medicine (MNMD – Research Report) today and set a price target of ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...